Literature DB >> 1998786

Picking up the tab for erythropoietin.

R Gabriel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1998786      PMCID: PMC1668950          DOI: 10.1136/bmj.302.6771.248

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  4 in total

1.  Effects of withdrawing erythropoietin.

Authors:  J E Taylor; I S Henderson; R A Mactier; W K Stewart
Journal:  BMJ       Date:  1991-02-02

Review 2.  Treatment of renal anemia with recombinant human erythropoietin.

Authors:  R M Schaefer; W H Hörl; S G Massry
Journal:  Am J Nephrol       Date:  1989       Impact factor: 3.754

3.  Over 50 and uremic equals death. The failure of the British National Health Service to provide adequate dialysis facilities.

Authors:  G M Berlyne
Journal:  Nephron       Date:  1982       Impact factor: 2.847

4.  Negative selection of patients for dialysis and transplantation in the United Kingdom.

Authors:  S Challah; A J Wing; R Bauer; R W Morris; S A Schroeder
Journal:  Br Med J (Clin Res Ed)       Date:  1984-04-14
  4 in total
  8 in total

1.  Picking up the tab for erythropoietin.

Authors:  P G Kopelman; C W Barrett
Journal:  BMJ       Date:  1991-06-01

2.  Picking up the tab for erythropoietin.

Authors: 
Journal:  BMJ       Date:  1991-03-09

3.  Picking up the tab for erythropoietin.

Authors:  A Hillis; J Marsden; T J Peters; R Sherwood
Journal:  BMJ       Date:  1991-04-13

4.  General practitioner prescribing of erythropoietin.

Authors:  S P Gibson; J B Hawkins; E S Nyholm
Journal:  BMJ       Date:  1991-10-26

5.  How to pay for expensive drugs.

Authors:  M Orme
Journal:  BMJ       Date:  1991-09-14

Review 6.  Epoetin: a pharmacoeconomic review of its use in chronic renal failure and its effects on quality of life.

Authors:  R Whittington; L B Barradell; P Benfield
Journal:  Pharmacoeconomics       Date:  1993-01       Impact factor: 4.981

Review 7.  Cyclosporin: a pharmacoeconomic evaluation of its use in renal transplantation.

Authors:  J E Frampton; D Faulds
Journal:  Pharmacoeconomics       Date:  1993-11       Impact factor: 4.981

8.  Cost benefits of low dose subcutaneous erythropoietin in patients with anaemia of end stage renal disease.

Authors:  M E Stevens; G P Summerfield; A A Hall; C A Beck; A J Harding; J R Cove-Smith; A D Paterson
Journal:  BMJ       Date:  1992-02-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.